Skip to content
10-Q

Quarterly Report

Alexza Pharmaceuticals Inc.

0001564590-16-019359

← back to feed
Filed
May 13, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · May 11, 2016 21.75M sh
Cash And Equivalents Q1 2016 · Mar 31, 2016 $4.5M
Cash And Equivalents Q1 2016 · Dec 31, 2015 $7.76M
Cash And Equivalents Q1 2016 · Mar 31, 2015 $11.09M
Cash And Equivalents Q1 2016 · Dec 31, 2014 $15.2M
Stockholders Equity Q1 2016 · Mar 31, 2016 −$74.34M
Stockholders Equity Q1 2016 · Dec 31, 2015 −$71.66M
Current Liabilities Q1 2016 · Mar 31, 2016 $60.35M
Current Liabilities Q1 2016 · Dec 31, 2015 $58.2M
Current Assets Q1 2016 · Mar 31, 2016 $7.44M
Current Assets Q1 2016 · Dec 31, 2015 $10.99M
Total Assets Q1 2016 · Mar 31, 2016 $10.58M
Total Assets Q1 2016 · Dec 31, 2015 $14.73M
Sga Expense Q1 2016 · Mar 31, 2016 $2.39M
Sga Expense Q1 2016 · Mar 31, 2015 $3.74M
Rd Expense Q1 2016 · Mar 31, 2016 $2.44M
Rd Expense Q1 2016 · Mar 31, 2015 $3.82M
Net Income Q1 2016 · Mar 31, 2016 −$3.36M
Net Income Q1 2016 · Mar 31, 2015 −$404K
Operating Income Q1 2016 · Mar 31, 2016 −$5.06M
Operating Income Q1 2016 · Mar 31, 2015 −$13M
Cost Of Revenue Q1 2016 · Mar 31, 2016 $945K
Cost Of Revenue Q1 2016 · Mar 31, 2015 $6.15M
Revenue Q1 2016 · Mar 31, 2016 $720K
Revenue Q1 2016 · Mar 31, 2015 $705K